31 results about "Digitalis" patented technology

The invention belongs to the technological field of the Chinese medicine, particularly relating to an extraction and separation processes of the active ingredients with the active function of treating the chronic glomerulonephritis. The mullein indican is the active compound researched and developed for many years in our research institute; the mullein indican is extracted, separated and refined from the digitalis leaf and is an active compound with the function of treating the chronic glomerulonephritis. The invention is the research result of many years held and developed by the Chinese Medicine Research Department of the Chinese Medicine Research Institute of China and is supported by the special fund of the Central Institute of the National Science and Technology Department; now the compound has been approved by the State Food and Drug Administration Bureau as the novel drug and the mechanism research of the treatment of the chronic nephritis has been completed; the pre-clinical research work includes the main pharmacodynamic experiment, the production technology experiment (including the industrialized extraction and separation processes), the quality control standard, the experiment of the affecting factors of the quality, the experiment of the long-term stability, the acute toxicity of the rat, the experiment of the long-term toxicity, the teratogenic and mutagenic experiment, the general pharmacological experiment, the pharmacokinetics experiment, and so on. The digitalis leaf is mainly produced in the Huaiqing area of the Henan province, and is also grown wild and cultivated in the Shaanxi, Hebei and other places of China.

The invention provides methods for (a) prolonging time to hospitalization for heart failure; (b) prolonging time to first hospitalization for heart failure; (c) reducing the total number of days a patient with heart failure spends in the hospital for heart failure for a single hospital stay (i.e., reducing the duration of a single hospital stay for a patient with heart failure); (d) reducing the total number of days a patient spends in the hospital for heart failure for multiple hospital stays (i.e., two or more hospital stays); (e) reducing the number of hospital admissions for heart failure; (f) reducing mortality and reducing hospitalizations for heart failure (e.g., the total number of days in the hospital and / or the number of hospital visits); (g) increasing the left ventricular ejection fraction in a heart failure patient; (h) treating a sexual dysfunction (e.g., erectile dysfunction and female sexual dysfunction) (j) treating a headache in a heart failure patient by administering a non-steroidal antiinflammatory compound (i.e., NSAIDs); (k) treating a heart failure patient who has a history of hypertension (but who is not currently diagnosed with hypertension); (l) improving the quality of life in a heart failure patient based on the Minnesota Living with heart failure questionnaire; (m) decreasing the levels of B-type natriuretic peptide; (n) treating hypertension in a heart failure patient; (o) lowering blood pressure in a heart failure patient; (p) treating labile hypertension; (q) treating idiopathic hypertension; (r) increasing patient compliance with medication dosing in a heart failure patient; (s) treating hypertension in a patient with a dilated heart; (t) treating ischemic disease and / or coronary artery disease; and (u) reducing cardiomegaly in a patient in need thereof comprising administering to the patient a therapeutically effective amount of (i) a hydralazine compound or pharmaceutically acceptable salt thereof, (ii) isosorbide dinitrate and / or isosorbide mononitrate, and (iii) optionally at least one compound selected from the group consisting of angiotensin converting enzyme inhibitors, β-adrenergic antagonists, angiotensin II antagonists, aldosterone antagonists, cardiac glucosides (digitalis), and diuretic compounds.

The invention provides methods for (a) prolonging time to hospitalization for heart failure; (b) prolonging time to first hospitalization for heart failure; (c) reducing the total number of days a patient with heart failure spends in the hospital for heart failure for a single hospital stay (i.e., reducing the duration of a single hospital stay for a patient with heart failure); (d) reducing the total number of days a patient spends in the hospital for heart failure for multiple hospital stays; (e) reducing the number of hospital admissions for heart failure; and (f) reducing mortality and reducing hospitalizations for heart failure (e.g., the total number of days in the hospital and / or the number of hospital visits) in a patient in need thereof comprising administering to the patient a therapeutically effective amount of (i) a hydralazine compound or pharmaceutically acceptable salt thereof, (ii) isosorbide dinitrate and / or isosorbide mononitrate, and (iii) optionally at least one compound selected from the group consisting of angiotensin converting enzyme inhibitors, β-adrenergic antagonists, angiotensin II antagonists, aldosterone antagonists, cardiac glucosides (digitalis), and diuretic compounds.

The invention discloses an ewe feed and a preparation method thereof, and belongs to the field of feeds. The ewe feed comprises the following raw materials in parts by weight: 50-60 parts of maize flour, 10-20 parts of peanut meal, 2-8 parts of rice bran, 2-8 parts of bone meal, 4-12 parts of cotton dregs, 10-20 parts of corn protein powder, 4-10 parts of soybean meal, 3-9 parts of millet, 2-8 parts of alfalfa meal, 1-3 parts of amino acid, 1-3 parts of a vitamin additive, 1-3 parts of table salt, 2-8 parts of digitalis, 4-10 parts of coriander seeds, 1-5 parts of common selfheal fruit-spike, 2-8 parts of cassia twigs, 1-5 parts of perilla stems, 4-8 parts of cortex magnoliae officinalis, 1-5 parts of great burdock achene, 2-6 parts of katsumada galangal seeds, and 2-8 parts of bighead atractylodes rhizomes. The ewe feed disclosed by the invention is scientific in formula and rich in nutrition, can adapt to the growth characteristic and the physiological characteristic of ewes, meet the requirements of nutrient components desired by the growth of the ewes, promote digestion and absorption, and besides, can improve the immunity and the resistance of the ewes.

The invention discloses a making method of tawny daylily, neotorularia humilis and cherry bread. The tawny daylily, neotorularia humilis and cherry bread is made by using tawny daylilies and cherries as raw materials, and simultaneously adding neotorularia humilis, rhizoma acori calami, barbary wolfberry fruits, radix polygonati officinalis, lisea coreana, red jujubes, digitalis, nardostachys roots, haws, radish seeds, radix paeoniae alba and cortex magnoliae officinalis. The nutrition and the health-care value of the tawny daylilies and the cherries are fully utilized, and the tawny daylilies, the cherries and traditional Chinese medicines are in mutual concerted application and synergistic interaction, so that the efficacies of stimulating the appetite, invigorating the spleen, relieving epigastric distention, regulating vital energy and the like are realized. Finished products are fragrant and sweet in mouth feel and rich in nutrition, have peculiar delicate fragrance of the tawny daylilies, and can obviously alleviate the physical discomfort of crowds suffering from indigestion, early satiety and belch for a long term after being eaten for a long term. The making method is simple in making technology, convenient to operate and broad in market prospects.

The invention discloses a traditional Chinese medicine preparation for treating miocardial infarction and a preparation method thereof, and belongs to the field of traditional Chinese medicines. The effective components of the traditional Chinese medicine preparation disclosed by the invention comprise the following raw materials: calcite, digitalis, inula flowers, twining rhynchosia herbs, herbs of common seseli, Yunnan glorybower root stems and leaves, forrest cranesbill roots, moellendorf spikemoss herbs, lepidogrammitis rostrata, lantern plant calyx, dioscorea nipponica, forbes wildginger herbs, latifolious rush rhizomes, dadvid bushclover roots or herbs, lignum dalbergiae odoriferae and luffa vegetable sponges. The medicinal materials selected by the traditional Chinese medicine preparation disclosed by the invention are appropriate in concerted application, the preparation conforms to traditional Chinese medicine and pharmacy and modern medicine theories, the preparation has efficacies of promoting qi circulation to relieve pain, promoting blood circulation for benefiting arteries and veins, relieving rigidity of muscles, activating collaterals, relieving restlessness and relieving pain, and the preparation has the advantages of convenient usage, good absorption effect and zero bad or toxic or side effects. Through clinical verification, the preparation has excellent relief and treatment effects on the miocardial infarction, and is suitable for the popularization and the application of clinical treatment and nursing of the miocardial infarction.

The invention discloses an external liquid medicine for skin diseases and a preparation technology thereof. The producing raw materials of the liquid medicine comprise tomato juice, bioactive active enzymes, preservatives and traditional Chinese medicine materials. The preparation method comprises the following steps: preparing mother liquid with the raw materials of the tomato juice, the bioactive mildew and the preservatives, wherein the weight proportion of the raw materials of the tomato juice to the raw materials of the bioactive mildew and the raw materials of the preservatives is 100:4:1, adding 0.8 kg of traditional Chinese medicine materials to every 4 liters of mother liquid which is made of the tomato juice, the bioactive active enzymes and the preservatives, soaking the traditional Chinese medicine material in the mother liquid to prepare the liquid medicine, and filtering the traditional Chinese medicine materials after the traditional Chinese medicine materials are soaked for 7-10 days. The bioactive active enzymes are bean curds which are fermented. The preservatives are sodium benzoate. A part of the medicine materials is prepared from 5 g of rhizoma anemarrhenae, 5 g of phellodendron, 4 g of tree peony bark, 4 g of poria cocos, 4 g of rhizoma alismatis, 3 g of Chinese yam, 3 g of cornel and 4 g of digitalis. The external liquid medicine for the skin diseases has the curative effects of clearing heat, removing toxicity and resisting allergy. The external liquid medicine is mainly used for treating the skin diseases, such as whelk, pollinosis, solar dermatitis, neurodermitis, beriberi, ringworm, empyrosis and infrared injury, and is used for expelling mosquitoes, relieving itching and the like.

Embodiments in the invention provide a fertilizer capable of promoting root absorption of flowers with abundant roots. The fertilizer is characterized by being prepared from the following raw materials by weight: 30 to 40 parts of leaf mould, 20 to 24 parts of lawn soil, 10 to 12 parts of potassium fulvic acid, 14 to 15 parts of silicon humate fertilizer, 6 to 8 parts of ground rock phosphate, 2 to 3 parts of digitalis, 4 to 5 parts of black pepper leaf, 10 to 14 parts of grape seed, 6 to 8 parts of brassinosteroid, 2 to 5 parts of oleander leaf, 0.5 to 1.2 parts of protease K, 0.3 to 0.5 part of 2,4-dichlorophenol-diethylstilbestrol, 0.2 to 0.5 part of calcium chloride, a cross-linking agent and a proper amount of water. According to the invention, boiling extract of the digitalis, black pepper leaf and oleander leaf, a calcium chloride solution and the protease K are added into the organic matter fertilizer composed of leaf mould, lawn soil, potassium fulvic acid, silicon humate fertilizer and ground rock phosphate, so permeability and absorption capability of cell walls of plant roots are improved.

The invention discloses a side slope vegetation recovery method applicable to construction in spring and summer. The method comprises the following steps of 1 arranging a slope surface, 2 hanging a net, 3 reinforcing an anchor nail, 4 erecting a vegetation plate, 5 spraying a base material and 6 spraying a seed layer, wherein plant seeds to be sprayed are a mixture of pioneer seeds, edificator andground covers. Seed germination rate experiments show that when the germination rates of the three sets of seeds are not lower than 80%, 20-100 g of pioneer seeds, 20-60 g of edificator and 10-30 g of ground covers are mixed per square meter, the pioneer seeds are one or more of smartweed, violet and digitalis, the edificator is one or more of thus javanica L., chrysanthemum flowers, cassia toraand Magnolia multiflora, and the ground covers are one or more of bluegrass, Tiflawn, Formosan grass, Bermuda grass, Eremochloa ophiuroides, Stenotaphrum helferi and buffalo grass; the ground is covered with a non-woven fabric. An existing technological process is not changed, on the premise that no construction cost is increased, the better side slope recovery effect is obtained, and rapid formation and sustainable development of target colonies are promoted.

The invention relates to special noodles for diabetics, and belongs to the fields of functional foods and clinical foods. The noodles are made through the following steps: taking the raw materials of 10-12g of ginseng, 8-15g of rhizoma coptidis, 5-10g of digitalis, 20-25g of buckwheat, 7-14g of Chinese wolfberries, 1-3g of American ginseng, 6-12g of endothelium corneum gigeriae galli, 13-18g of Chinese yam, 8-10g of corn stigma, and 7-9g of pseudo-ginseng, enabling the raw materials to be made into fine powder, and thoroughly mixing the fine powder with flour so as to process noodles, so that the made noodles are fine and smooth in mouth feel, and not only have the effect of reducing blood sugar, but also can improve the immunity of patients suffering from diabetes, and the patients suffering from diabetes can eat a cooked wheaten food without needing dieting. Examples prove that after the special noodles disclosed by the invention are eaten for a long term, very good effects of reducing blood sugar for the patients suffering from the diabetes, and improving the immunity of bodies of the patients suffering from the diabetes can be achieved.

The invention discloses an external traditional Chinese medicine ointment for treating myopia and a preparation method thereof, and belongs to the technical field of traditional Chinese medicines. The traditional Chinese medicine ointment comprises rhizoma acori graminei, radix polygalae, radix angelicae sinensis, fructus broussonetiae, fructus corni, semen cuscutae, fructus lycii, radix salviae miltiorrhizae, rhizoma chuanxiong, radix codonopsis, radix astragali, rhizoma atractylodis macrocephalae, pericarpium citri reticulatae viride, digitalis, cortex fraxini, radix paeoniae alba, radix rubiae and the like. According to the external traditional Chinese medicine ointment for treating myopia and the preparation method of the external traditional Chinese medicine ointment, the raw material formula is selected, the process is simple, and the obtained external traditional Chinese medicine ointment for treating myopia can be directly applied, is convenient to use, has the effects of promoting periorbital blood circulation, relieving eye muscle spasm and eliminating eye fatigue, has a remarkable myopia treatment effect and has good economic and social benefits.

The invention relates to a pharmaceutical composition for preventing and treating dorking abdominal dropsy generated during later feeding period, which is characterized by uniformly mixing the following components by weight: 10-100 mg of dihydrochlorothiazide and 50-500 mg of digitalis leaf ultrafine powder, wherein the components are added to dorking daily feeds per kilogram for feeding by weight. In the invention, the dihydrochlorothiazide plays a diuresis role by suppressing the reabsorption of natrium ions and chloride ions, assists organisms to eliminate seroperitoneum, is used as a diuretic with moderate efficacy and has gentle effect, thereby being suitable for large dorkings with certain-degree heart failures; in addition, the digitalis leaf ultrafine powder can increase myocardialcontraction force and cardiac output and reduce myocardial oxygen consumption, thereby improving the right heart failure condition. The invention has simple prescription and reasonable preparation and can play good role in preventing and treating the dorking abdominal dropsy generated during the later feeding period after being added to the dorking feeds per kilogram.

The invention provides a making method of fresh digitalis powder and fresh digitalis powder medicinal slices. The making method of the fresh digitalis powder comprises the steps of 1, collecting freshdigitalis, cleaning the fresh digitalis, and obtaining a raw clear material; 2, smashing and juicing the raw fresh digitalis clear material; 3, adding a covering material, and sufficiently mixing thecovering material and digitalis juice; 4, freeze-drying the mixture obtained in step 3; 5 performing micronizing on the freeze-dried medicine. According to the preparation method, the content of catalpa and verbascoside can be kept stable, loss in the drying process is avoided, and the blood cooling effect of the fresh digitalis is reserved basically.

The invention provides digitalis pickled vegetables with multiple tastes. The digitalis pickled vegetables are prepared through the following steps: using digitalis as a main raw material, screening the digitalis, cleaning the digitalis, cutting the digitalis into digitalis sheets, seasoning and preserving the digitalis sheets, and sterilizing the digitalis sheets to obtain the digitalis pickled vegetables. The digitalis sheets which are cut are preserved by various seasonings to have needed tastes. The digitalis pickled vegetables integrate medicine and food into a whole; the digitalis pickled vegetables are convenient to eat, and diversified in the tastes; the digitalis pickled vegetables not only are a table dish but also health-care food; the digitalis pickled vegetables contain various components which are beneficial to health; when the digitalis pickled vegetables are eaten by a person, the person can feel slightly bitter first and then slightly sweet, the flavor of the digitalis pickled vegetables is unique; if people often eat the digitalis pickled vegetables, the digitalis pickled vegetables not only can supplement various vitamins and minerals but also can have the effects of nourishing yin, tonifying blood, reducing blood sugar, raising blood pressure, promoting diuresis, resisting bacteria, protecting liver, and treating the diseases of fever due to yin deficiency, night sweating, dry mouth and polydipsia, yin deficiency, constipation and the like.

The invention discloses a high security vena digitalis verification entrance guard system and an unlocking method. The high security vena digitalis verification entrance guard system comprises an entrance guard lock, a vena digitalis acquisition module, a local server, a re-verification unlocking module, a prompt module and a rechargeable module, wherein the local server is electrically connected to the vena digitalis acquisition module, the re-verification unlocking module, and the entrance guard lock. According to the present invention, the vena digitalis image verification is used as the first layer verification, and the second secret key generated by re-compilation through the ID card is used as the second layer verification, such that the vena digitalis and the ID card become the separated verification ways, ie., the staff picking the card cannot directly open the entrance guard lock through the single ID card even if the ID card is lost, and the replacement of the card reading of the partial staffs with the card reading of other staffs can be effectively avoided, wherein the partial staffs want to escape from the working attendance check; and the vena digitalis image is used as the first layer verification so as to improve the use security and the reliability of the entrance guard system.

The invention discloses vena digitalis dorsalis and finger dorsum line combined acquisition recognition device and method. The device comprises an outer shell, a multi-band light source, a broad bandpass filter, an image acquisition device and a main processing module, wherein a finger slot is formed in the top of the outer shell; the multi-band light source comprises a visible light and an infrared light, and is arranged on the outer shell above the finger slot, and light faces the finger slot; the board band pass filter, the image acquisition device and the main processing module are all arranged in the outer shell, the broad band pass filter is arranged right below the finger slot in a horizontal direction, the image acquisition device comprises a lens and an image sensor, only one setof image acquisition device is arranged, the lens is arranged on a light path behind the broad band pass filter, the image sensor is arranged on the light path behind the lens, and the multi-band light source and the image sensor are respectively electrically connected with the main processing module. The invention solves the problem in the prior art that one camera cannot acquire vena digitalisand finger dorsum line at the same time as one image for combined recognition, the device volume is reduced, and power consumption is reduced.

The invention discloses a preparation method of a standard digoxin substance. The preparation method includes: subjecting crude digoxin to activated carbon fading, liquid-liquid extraction and solventcrystallization. The preparation method of the standard digoxin substance has the advantages that micro impurities having influence on color of a digoxin product can be removed, the digoxin product can be whiter in color; digoxin can be effectively separated from impurities including digitalis, hydroxy digitoxin and the like, purity of the digoxin product can be improved effectively; impurities structurally similar to dihydroxy digitoxin can be separated out from the digoxin product, and the purity of the digoxin product can be over 99.5%; an obtained crystal digoxin product with content higher than 99.5% (measured by an HPLC-high performance liquid chromatography method) can be applied to crude digoxin drug monitoring and blood concentration monitoring and is simple in preparation method.

The invention relates to a feed for tiger frogs. The feed consists of the following components in compounding ratio: flour, soybean meal, fish meal, meat and bone meal, rice bran, tea leaf powder, soybean oil, calcium dihydrogen phosphate, choline chloride, a nutrient composition, immature orange fruits, medicated leaven, Chinese rhubarb, dried digitalis, smoked plums, phellodendron and bighead atractylodes rhizomes. The preparation method comprises the following steps: firstly grinding the immature orange fruits, the medicated leaven, the Chinese rhubarb, the dried digitalis, the smoked plum, the phellodendron and the bighead atractylodes rhizomes into powder of 200-300 meshes; pouring the powder, the flour, the soybean meal, the fish meal, the meat and bone meal, the rice bran and the tea leaf powder in an agitator tank together, and uniformly stirring the powder, the flour, the soybean meal, the fish meal, the meat and bone meal, the rice bran and the tea leaf powder; adding soybean oil; dissolving the calcium dihydrogen phosphate, the choline chloride and the nutrient composition in water so as to obtain a solution; pouring the solution in the agitator tank, and stirring the solution and mixed components together; pouring clean water until all of the powder is wet; and finally pouring the wet powder into a bulking machine to be processed into the bulking feed.

The invention discloses refined chicken feed containing seaweed.The chicken feed is prepared from the following raw materials in parts by weight: 20-25 parts of oat, 1-2 parts of blood powder, 3-5 parts of corn protein powder, 80-90 parts of flour, 10-20 parts of corns, 1-2 parts of yeast, 3-5 parts of seaweed powder, 0.02-0.04 part of tender uncaria, 0.2-0.3 part of platycodon roots, 0.2-0.4 parts of adhesive rehmannia flowers, 0.2-0.4 part of glossy ganoderma, 1-2 parts of oolong, 0.1-0.2 part of licorice roots, 5-7 parts of compounding almond sauce, and an appropriate amount of water. The chicken feed is easily digested, multiple raw materials are used for synergistic action, so that the chicken feed has the effects of health care and disease prevention; the tender uncaria can be used for clearing heat and calming the liver; the adhesive rehmannia flowers are mainly buds of scrophulariaceae plant digitalis, and have the efficacy of treating diabetes and lumbago due to the kidney deficiency.

The invention provides methods for (a) prolonging time to hospitalization for heart failure; (b) prolonging time to first hospitalization for heart failure; (c) reducing the total number of days a patient with heart failure spends in the hospital for heart failure for a single hospital stay (i.e., reducing the duration of a single hospital stay for a patient with heart failure); (d) reducing the total number of days a patient spends in the hospital for heart failure for multiple hospital stays; (e) reducing the number of hospital admissions for heart failure; and (f) reducing mortality and reducing hospitalizations for heart failure (e.g., the total number of days in the hospital and / or the number of hospital visits) in a patient in need thereof comprising administering to the patient a therapeutically effective amount of (i) a hydralazine compound or pharmaceutically acceptable salt thereof, (ii) isosorbide dinitrate and / or isosorbide mononitrate, and (iii) optionally at least one compound selected from the group consisting of angiotensin converting enzyme inhibitors, β-adrenergic antagonists, angiotensin II antagonists, aldosterone antagonists, cardiac glucosides (digitalis), and diuretic compounds.

The present invention provides methods of treating and preventing mortality associated with heart failure in an African American patient with hypertension and improving oxygen consumption, quality of life and exercise tolerance by administering a therapeutically effective amount of at least one hydralazine compound and at least one of isosorbide dinitrate and isosorbide mononitrate, and, optionally, one or more compounds, such as, for example, a digitalis, a diuretic compound, or a compound used to treat cardiovascular diseases. In the present invention, the hydralazine compound is preferably hydralazine or a pharmaceutically acceptable salt thereof. Preferred methods of the invention comprise administering hydralazine or a pharmaceutically acceptable salt thereof and isosorbide dinitrate.

The invention discloses a preparation method of radix isatidis Erhuang powder for treating an infectious bursal disease of chickens. The powder is prepared from the traditional Chinese medicine raw materials in parts by weight: 25-40 parts of radix isatidis, 25-35 parts of fructus forsythiae, 40-50 parts of bighead atractylodes rhizomes, 50-70 parts of radix astragali, 30-40 parts of cortex phellodendri, 25-40 parts of haws, 30-40 parts of digitalis, and 35-45 parts of herba epimedii. The preparation method comprises the steps of (1) crushing radix astragali, cortex phellodendri, haws, digitalis and herba epimedii, and adding compound enzymes for enzymolysis; (2) performing extraction twice; (3) performing concentration so as to obtain a medicinal extract; (4) separately crushing radix isatidis, fructus forsythiae, and bighead atractylodes rhizomes so as to obtain radix isatidis powder, fructus forsythiae powder and bighead atractylodes rhizome powder; (5) mixing the radix isatidis powder with the medicinal extract, performing pelletization, performing granule tidying, performing drying, adding the fructus forsythiae powder and the bighead atractylodes rhizome powder, performing uniform mixing and performing screening; and (6) performing packaging. According to the preparation method of the radix isatidis Erhuang powder for treating the infectious bursal disease of chickens, disclosed by the invention, the radix isatidis Erhuang powder has a notable treatment effect on the infectious bursal disease, and the dissolution rate of effective components of medicinal materials is increased.

The invention discloses a special dopamine medicine formula for congestive heart failure. The dopamine medicine formula comprises the following raw materials (in percentage by mass): 15-18 parts of dopamine; 11-13 parts of a radix salviae miltiorrhizae extract; 11-13 parts of an angelica sinensis extract; 11-13 parts of a ligusticum wallichii extract; 8-11 parts of digitalis; 8 to 11 parts of honeysuckle flower; 8-11 parts of radix paeoniae rubra; 8-11 parts of semen lepidii; and 6-9 parts of borneol. According to the invention, scientific and reasonable proportioning is adopted; the dopaminemedicine special for congestive heart failure is prepared from dopamine, the salvia miltiorrhiza extract, the angelica sinensis extract, the ligusticum wallichii extract, digitalis, honeysuckle, radixpaeoniae rubra, semen lepidii and borneol. The main components of the medicine are extracted from Chinese herbal medicine plants, so that the medicine is small in side effect, suitable for most patients with congestive heart failure, and the medicine effect maintaining time is long, the patients only need to take the medicine once a day, the frequency of taking the medicine by the patients is reduced, and normal life of the patients is facilitated.

The invention belongs to the biotechnical field, and discloses a method for preparing endogenous digitalis factors. The method disclosed by the invention organically combines an ultrafiltration technology with an antibody technology to exclusively separate endogenous digitalis-like factors from tissues, so that the problem for a long time that the endogenous digitalis factors are hard to separate due to too low content of the endogenous digitalis factors in the tissues and too many impurities with similar molecular weights. The method disclosed by the invention has the characteristics of simple and convenient operational method, strong specificity and the like.

The invention relates to a Chinese herbal medicine preparation, which is characterized in that the Chinese herbal medicine preparation is prepared by using the Chinese herbal medicine plants, sealing, performing hot dipping, filtering and extracting Chinese herbal medicine insecticide components, and the Chinese herbal medicine insecticidal preparation can be used for substituting a chemical pesticide. A processing method comprises the following steps: making a formula of the nuisance-free pesticide preparation, purchasing the raw materials, performing rough machining on the raw materials, sealing and performing hot dipping, filtering, depositing a filtrate, and packaging the finished product. According to the invention, monkshood, daturae flower, edible tulip bulb, bitter apricot kernel, digitalis and croton seed with equal amount are purchased, 6 parts of screw-shaped pepper with strong spicy are employed, monkshood, daturae flower, edible tulip bulb, bitter apricot kernel, digitalis and croton seed are crushed by a screen mesh with diameter being 0.5 centimeters, the screw-shaped pepper is crushed by an ultrafine pulverizer with 300 meshes, the screw-shaped pepper is mixed with monkshood, daturae flower, edible tulip bulb, bitter apricot kernel, digitalis and croton seed, the raw materials and water are added in an integrated apparatus of sealing, hot-dipping and filtering according to proportion being 5: 100, wherein the hot dipping time is 1 hour, then a valve at bottom of an external cylinder of the hot dipping apparatus is opened, a hot dipping liquid is placed in a stainless steel container, then is deposited for 15-20 days to obtain a supernatant of a filtrate, and the supernatant is the nuisance-free pesticide preparation.

To provide a safe skin preparation for external use for hair growth which can be used regardless of gender and has an excellent hair growth effect. This skin preparation for external use for hair growth is characterized by containing at least one of Quillaja saponin and a steroid saponin as an active ingredient. Preferably, the steroid saponin is at least one selected from the group consisting ofSarsasaponin, Timosaponin, Digitalis saponin, Dioscorea japonica saponin, and Ophiopogon saponin. More preferably, the steroid saponin is Sarsasaponin.

The invention belongs to the field of fertilizer research and discloses fertilizer for promoting absorption of roots of multi-root flowers and a preparation method thereof. The fertilizer is prepared from 30-40 parts by weight of leaf mold, 20-24 parts by weight of lawn soil, 10-12 parts by weight of potassium fulvate, 14-15 parts by weight of humic acid silicon fertilizer, 6-8 parts by weight of phosphate rock powder, 2-3 parts by weight of digitalis, 4-5 parts by weight of black pepper leaves, 10-14 parts by weight of grape seeds, 6-8 parts by weight of brassinosteroid, 2-5 parts by weight of oleander leaves, 0.5-1 part by weight of protease K, 0.3-0.5 parts by weight of 2, 4-dichlorophenol ethyl phenol, 0.2-0.5 parts by weight of calcium chloride, a crosslinking agent and an appropriate amount of water.

The invention belongs to the technical field of medicines, and relates to a phenytoin sodium dropping pill and a preparation method thereof. The phenytoin sodium dropping pill is applicable to treatment of generalized tonic-clonic seizures, complex partial seizures (psychomotor seizures and temporal lobe epilepsy) simple partial seizures (focal seizures) and status epilepticus, can also be used for treating trigeminal neuralgia, epidermolysis bullosa dystrophica recessive, paroxysmal choreoathetosis, paroxysmal control disorders (including behavioral disorders caused by hyperexcitability such as rage, anxiety, insomnia and the like), myotonia, cardiac conduction disorder during overdose of a tricyclic antidepressant and the like, and is also applicable to ventricular and supraventricular arrhythmias caused by digitalis toxication, with a poor therapeutic effect on cardiac arrhythmias caused by other various causes. Compared with currently marketed tablet products, the phenytoin sodium dropping pill has the characteristics of simple and feasible preparation process, rapid absorption and high bioavailability.

The invention discloses an oil suspending agent for preventing and treating phyllotreta vittata. The oil suspending agent for preventing and treating phyllotreta vittata comprises the following raw materials in parts by weight: 30-50 parts of folium digitalis, 22-36 parts of gelsmium elegans, 15-37 parts of Atropa belladonna, 10-18 parts of purslane, 5-15 parts of an emulsifier, 4-8 parts of a dispersing agent, 3-9 parts of a wetting agent, 2-6 parts of a thickening agent, 3-7 parts of an antifreezing agent, and 50-70 parts of a disperse medium. The oil suspending agent takes Chinese herbal medicines of folium digitalis, gelsmium elegans, Atropa belladonna and purslane as an effective component after being processed, the oil suspending agent can be obtained by adding the auxiliary materials of the emulsifier, the dispersing agent, the wetting agent and the thickening agent, through dilution, the oil suspending agent can be applied in the field of cruciferous vegetables, and especially aims at prevention and treatment of phyllotreta vittata. The oil suspending agent has the advantages of good dispersion performance, strong stickiness, rainwash resistance, and high active ingredient utilization rate, and the oil suspending agent has excellent prevention and treatment effects for phyllotreta vittata.

The invention discloses a medicine for preventing lung cancer postoperative complications of a cardiovascular system. The medicine comprises the following raw materials: digitalis, orchis, ligusticum wallichii, pyrola, grape, symplocarpus foetidus, ginseng fruit, ganoderma lucidum, fructus kochiae, star grass, jujube, Chinese yam, agaric, jasmine flower, albizia flower, orchids, longan pulp, buckbean, lotus seeds, cinnamon, spi-raea faponica, acanthopanax, salsola, prepared radix licorice and dried tangerine peel. The medicine has the advantages that the medicine reduces the lung cancer postoperative complications of the cardiovascular system and is safe and free of non-toxic and side effects, a good curative effect can be achieved only by a small amount of medicine, and the medicine has a very good effect on patients.